Critical Metals (CRML) stock jumps 10% as Saudi rare-earth talks resurface in filing

Critical Metals (CRML) stock jumps 10% as Saudi rare-earth talks resurface in filing

Critical Metals shares surged about 10% Friday after a filing disclosed a non-binding Saudi MoU and four non-binding offtake term sheets tied to its Tanbreez project. The stock closed at $20.34, up $1.88, with volume over 39 million shares. Traders are watching for binding contracts and further disclosures. The company holds a 42% stake in Tanbreez and aims to expand rare-earth processing.
23 January 2026
Why Voyager Technologies (VOYG) stock is up today: Wedbush Outperform call meets ISS drug-research deal

Why Voyager Technologies (VOYG) stock is up today: Wedbush Outperform call meets ISS drug-research deal

Voyager Technologies shares rose 6.4% to $36.80 Friday after Wedbush initiated coverage with an Outperform rating and $46 target. The move followed Voyager’s announcement of a new ISS drug-discovery payload deal with Space LiinTech. Trading volume reached 2.24 million shares. Voyager went public in June and is developing the NASA-backed Starlab space station.
23 January 2026
IBM stock slides in afternoon trade as investors brace for earnings and fresh security news

IBM stock slides in afternoon trade as investors brace for earnings and fresh security news

IBM shares fell 1.1% to $291.51 Friday, underperforming other tech giants as traders braced for next week’s earnings and 2026 guidance. IBM Consulting announced a new “quantum-safe” security partnership, while analysts highlighted renewed software growth and the pending $11 billion Confluent deal. The company reports Q4 results on Jan. 28.
Applied Digital (APLD) stock jumps nearly 9% on Delta Forge AI data center build — what to watch next

Applied Digital (APLD) stock jumps nearly 9% on Delta Forge AI data center build — what to watch next

Applied Digital shares rose about 9% to $37.90 Friday after breaking ground on its Delta Forge 1 AI data center campus in Louisiana, designed for 430 megawatts of utility power. A Roth note expects a major tenant lease at the site within months. The company aims for initial operations by mid-2027. Investors are watching for a signed lease and financing details.
TMC stock jumps on first-of-its-kind U.S. deep-sea mining application

TMC stock jumps on first-of-its-kind U.S. deep-sea mining application

TMC shares jumped 14% Friday after its U.S. unit filed the first consolidated application under new federal rules to mine metal-rich seabed nodules. The filing seeks permits for a 65,000-square-kilometer area in the Clarion-Clipperton Zone. Trading volume neared 19.7 million shares. The new process allows companies to apply for exploration and recovery permits at the same time.
23 January 2026
Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play

Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play

Boston Scientific shares rose about 1% to $92.20 Friday, outperforming a weaker healthcare sector as investors focused on pulsed-field ablation for atrial fibrillation. The company’s $14.5 billion deal to buy Penumbra and its upcoming Feb. 4 earnings report are drawing scrutiny. Johnson & Johnson posted $24.6 billion in quarterly sales and gave 2026 guidance, while Medtronic and Abbott shares fell.
23 January 2026
SLB stock price swings after earnings beat, dividend hike and Venezuela signals

SLB stock price swings after earnings beat, dividend hike and Venezuela signals

SLB reported Q4 adjusted earnings of 78 cents per share, beating forecasts, and raised its dividend by 3.5% to $0.295. Shares rose 0.3% to $49.47 after early gains faded. The company set 2026 revenue guidance up to $37.7 billion and plans to return over $4 billion to shareholders. CEO Olivier Le Peuch cited rising customer interest in Venezuela but said expansion depends on licenses and payment terms.
Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead Sciences shares rose 3.5% to $135.73 Friday, hitting new highs after Phase 3 trial data showed its Trodelvy-Keytruda combo cut the risk of disease progression or death by 35% in metastatic triple-negative breast cancer. Gilead has filed for expanded approval in the U.S. and Europe. Volume reached 8.8 million shares. A Form 144 filing showed executive Deborah Telman plans to sell up to 29,215 shares.
Maase stock jumps on Huazhi AI acquisition plan — what MAAS investors watch next

Maase stock jumps on Huazhi AI acquisition plan — what MAAS investors watch next

Maase Inc shares surged 7.8% to $6.05 after announcing its $157.1 million acquisition of Times Good Limited, adding China’s Huazhi Group. The deal includes 87.4 million new shares and $26 million cash, with sellers facing a 60-month lock-up. Maase’s stock hit a 52-week high of $6.95 before paring gains. The share portion is priced at $1.50, well below Friday’s close, raising volatility concerns.
23 January 2026
Why Navitas Semiconductor (NVTS) stock is down today — and what traders watch next

Why Navitas Semiconductor (NVTS) stock is down today — and what traders watch next

Navitas Semiconductor fell 10% to $10.15 Friday afternoon, reversing Thursday’s rally as chip stocks dropped after Intel’s 18% plunge on weak guidance. Trading volume in Navitas hit 24 million shares by mid-afternoon. Wolfspeed, onsemi, and Monolithic Power Systems also declined. Investors are watching the Fed’s Jan. 27-28 meeting and upcoming tech earnings.
FTAI Aviation stock drops in New York trade as investors weigh CFM56 pact and fresh BTIG target hike

FTAI Aviation stock drops in New York trade as investors weigh CFM56 pact and fresh BTIG target hike

FTAI Aviation shares fell 1.2% to $289.86 Friday afternoon, following the announcement of a multi-year CFM56 engine support deal with CFM International. The agreement gives FTAI direct access to OEM parts and repairs. Analyst Andre Madrid raised his price target to $335, citing the deal’s strategic value. FTAI will report Q4 and full-year results on Feb. 25.
23 January 2026
Life360 stock jumps 22% as record Q4 user growth lifts outlook ahead of March results

Life360 stock jumps 22% as record Q4 user growth lifts outlook ahead of March results

Life360 shares jumped 22% Friday after the company reported record Q4 user and subscriber growth and raised its 2025 revenue and adjusted EBITDA forecasts. The stock reached $66.90 in afternoon trading, up $12.09. Global monthly active users rose to 95.8 million, with 2.8 million paying circles. Full-year results and 2026 guidance are set for release March 2.
Applied Digital (APLD) stock jumps on 430-MW Delta Forge AI campus build; location due in February

Applied Digital (APLD) stock jumps on 430-MW Delta Forge AI campus build; location due in February

Applied Digital shares rose 9.8% to $38.13 Friday after the company announced it broke ground on a new AI data center campus, Delta Forge 1, in the southern U.S. The facility targets 430 MW of utility power and aims to start operations by mid-2027. Investors pressed for tenant and location details; the CEO said the site will be revealed in February. No tenants have been named.
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue shares rose 0.1% to $17.77 Friday as investors await a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal would give Kenvue holders $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share. Institutional Shareholder Services recommended approval but cited litigation risks. Trading volume has surged ahead of the vote.

Stock Market Today

Go toTop